Optic Neuritis

• 

  Subject Areas on Research

  • A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. 
  • Acute inflammatory demyelinating optic neuritis: current concepts in diagnosis and management. 
  • Acute inflammatory demyelinating optic neuritis: evidence-based visual and neurological considerations. 
  • Anti-Myelin Oligodendrocyte Glycoprotein Optic Neuritis or Neuroretinitis? 
  • Anti-phospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS? 
  • Design, methods, and conduct of the Optic Neuritis Treatment Trial. 
  • Foster Kennedy syndrome. 
  • High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial. 
  • Latitudinal variation in incidence and type of first central nervous system demyelinating events. 
  • Macular star in neuroretinitis. 
  • Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. 
  • Necrotizing retinopathy with herpes zoster ophthalmicus: a light and electron microscopical study. 
  • Neurologic impairment 10 years after optic neuritis. 
  • Optic neuritis in Singapore. 
  • Pars planitis: clinical features and class II HLA associations. 
  • Pediatric optic neuritis. 
  • Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial. 
  • The clinical presentation and treatment of MOG antibody disease at a single academic center: A case series. 
  • The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group. 
  • The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group. 
  • The incidence of neuro-ophthalmic diseases in Singapore: a prospective study in public hospitals. 
  • The ocular manifestations of Wegener's granulomatosis. Fifteen years experience and review of the literature. 
  • The retinal lesions of the acquired immune deficiency syndrome. 
  • Visual function 15 years after optic neuritis: a final follow-up report from the Optic Neuritis Treatment Trial. 
  • Visual function 5 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. The Optic Neuritis Study Group. 
  • Visual function at baseline and 1 month in acute optic neuritis: predictors of visual outcome. 
  • Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial.